Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib in Systemic Sclerosis
NCT01166139Phase 2Completed
- Sponsor
- Hospital for Special Surgery
- Start
- Jul 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nilotinib in systemic sclerosis (SSc), sponsored by Hospital for Special Surgery. Started Jul 2010; status: completed.
02
Drugs
nilotinib
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT01166139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01166139.